IGHG3 and COVID-19: Likewise, the Ad26/Ad5 vaccinees differed from COVID-19-convalescent individuals, all of whom produced IgM and IgG1, and a fraction also had IgG2, IgG3, IgG4, and IgA1 (Figure 5).